These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12580871)

  • 41. Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck oncology.
    Bernier J; Bentzen SM
    Eur J Cancer; 2003 Mar; 39(5):560-71. PubMed ID: 12628834
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
    Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Adjuvant chemotherapy improves survival in head and neck tumors].
    Wendt TG
    Strahlenther Onkol; 1995 Dec; 171(12):719-20. PubMed ID: 8545798
    [No Abstract]   [Full Text] [Related]  

  • 44. Radiation and chemotherapy as combined treatment for advanced head and neck cancer.
    Witt ME
    Medsurg Nurs; 1998 Jun; 7(3):159-64. PubMed ID: 9727134
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia.
    Carlson DJ; Keall PJ; Loo BW; Chen ZJ; Brown JM
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1188-95. PubMed ID: 21183291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New trends in radiotherapy for head and neck cancer.
    Bourhis J; Etessami A; Lusinchi A
    Ann Oncol; 2005; 16 Suppl 2():ii255-7. PubMed ID: 15958468
    [No Abstract]   [Full Text] [Related]  

  • 47. Hypofractionated accelerated radiotherapy with concurrent carboplatin for locally advanced squamous cell carcinoma of the head and neck.
    Chan AK; Sanghera P; Choo BA; McConkey C; Mehanna H; Parmar S; Pracy P; Glaholm J; Hartley A
    Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):34-9. PubMed ID: 20863676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypofractionated radiotherapy plus cetuximab in locally advanced head and neck cancer.
    Teoh DC; Rodger S; Say J; Hartley A
    Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):717. PubMed ID: 18757187
    [No Abstract]   [Full Text] [Related]  

  • 49. Chemotherapy and altered fractionation in head-and-neck cancer: in regard to Staar et al., IJROBP 2001;50:1161-1171.
    Bentzen SM; Bernier J
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1423; author reply 1423-4. PubMed ID: 11955758
    [No Abstract]   [Full Text] [Related]  

  • 50. In response to Drs. Dubben, Beck-Bornholdt, and Llogie.
    Ang KK; Berkey BA; Pajak TF; Fu KK
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1148-50. PubMed ID: 11958923
    [No Abstract]   [Full Text] [Related]  

  • 51. Head and neck cancers: making headway in their treatment?
    McCann J
    J Natl Cancer Inst; 2000 Jan; 92(1):11-3. PubMed ID: 10620623
    [No Abstract]   [Full Text] [Related]  

  • 52. The value of adjuvant misonidazole in the definitive irradiation of advanced head and neck squamous cancer: an RTOG pilot study (#78-02).
    Fazekas JT; Goodman RL; McLean CJ
    Int J Radiat Oncol Biol Phys; 1981 Dec; 7(12):1703-8. PubMed ID: 7333912
    [No Abstract]   [Full Text] [Related]  

  • 53. Advances in chemotherapy for head and neck cancer.
    Bhide SA; Nutting CM
    Oral Oncol; 2010 Jun; 46(6):436-8. PubMed ID: 20400360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Chemotherapy and radiochemotherapy in tumors of the head-neck area].
    Metelmann HR
    Mund Kiefer Gesichtschir; 2000 May; 4 Suppl 1():S155-9. PubMed ID: 10938655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiotherapy compliance is maintained with hypofractionation and concurrent cetuximab in locally advanced head and neck cancer.
    Chan A; Teoh D; Sanghera P; Hartley A
    Radiother Oncol; 2009 Dec; 93(3):654. PubMed ID: 19524312
    [No Abstract]   [Full Text] [Related]  

  • 56. Current concepts of management in radiotherapy for head and neck squamous-cell cancer.
    Mazeron R; Tao Y; Lusinchi A; Bourhis J
    Oral Oncol; 2009; 45(4-5):402-8. PubMed ID: 19375379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Criteria for the determination of the efficacy of chemotherapy in head and neck cancer].
    Inuyama Y
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2681-9. PubMed ID: 3740865
    [No Abstract]   [Full Text] [Related]  

  • 58. Altered fractionation and adjuvant chemotherapy for head and neck squamous cell carcinoma.
    Mendenhall WM; Riggs CE; Vaysberg M; Amdur RJ; Werning JW
    Head Neck; 2010 Jul; 32(7):939-45. PubMed ID: 19894219
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In regard to Staar et al.: Intensified hyperfractionated accelerated radiotherapy limits the additional benefits of simultaneous chemotherapy-results of a multicentric randomized German trial in advanced head-and-neck cancer. IJROBP 2001;50:1161-1171.
    Grabenbauer GG; Sauer R
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):300. PubMed ID: 12183004
    [No Abstract]   [Full Text] [Related]  

  • 60. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.
    Staar S; Rudat V; Stuetzer H; Dietz A; Volling P; Schroeder M; Flentje M; Eckel HE; Mueller RP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1161-71. PubMed ID: 11483325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.